Low‐dose interleukin‐2 promotes STAT‐5 phosphorylation, Treg survival and CTLA‐4‐dependent function in autoimmune liver diseases
暂无分享,去创建一个
D. Adams | Y. Oo | G. Hirschfield | G. Webb | P. Lutz | H. Jeffery | L. Jeffery | M. Corrigan | Y. Oo | M. Corrigan | D. Adams